Financings
Realbotix Completes C$7,000,000 Brokered Life Offering

XBOT · Price
Executive Summary
- Realbotix Corp. closed an upsized brokered private placement of 14,000,000 units at C$0.50 per unit, raising gross proceeds of C$7 million.
- Each unit consists of one common share and one common‑share purchase warrant (exercise price C$0.75, exercisable through 24 Oct 2030).
- Net proceeds will be used to advance engineering, design and commercialization of AI‑powered humanoid robots and for general corporate purposes.
Key Details
- Offering Size & Price: 14,000,000 units @ C$0.50 per unit = C$7,000,000 gross proceeds.
- Unit Composition: 1 common share + 1 warrant (right to purchase one additional common share at C$0.75).
- Warrant Terms: Exercise price C$0.75; exercisable any time on or before 24 Oct 2030; subject to adjustment.
- Agent & Placement Agents: A.G.P. Canada Investments ULC – sole bookrunner/agent; A.G.P./Alliance Global Partners – sole U.S. placement agent.
- Commission Paid: Cash commission equal to 7.0% of the offering amount paid to the Agent.
- Broker Warrants Issued: 980,000 non‑transferable warrants issued to the Agent (exercise price C$0.75, same expiry as unit warrants); subject to a four‑month hold period under Canadian law.
- Use of Proceeds: Advance engineering, design and commercialization of AI‑powered humanoid robots; working capital; general corporate purposes.
- Regulatory Framework: Offering conducted under NI 45‑106 prospectus exemptions and the Listed Issuer Financing Exemption; securities not subject to a hold period (except broker warrants).
- U.S. Restrictions: Securities not registered in the United States and may not be offered or sold there unless an exemption is available.
Notable Quotes
- “We are pleased to successfully complete this Offering, which provides Realbotix with the capital to achieve our objectives for the foreseeable future… With a strong balance sheet, we are confident in our ability to deploy this capital strategically to deliver strong returns on investment.” – Andrew Kiguel, Executive Chairman & CEO.
More from Realbotix Corp.
Jun 24, 2026 · 07:30